Skip to main content
SpringerLink
Log in

Home Haemodialysis in Children

  • Chapter
  • First Online:
Pediatric Dialysis

  • 789 Accesses

Abstract

Home haemodialysis (HHD) is not a novel concept but one that has resurfaced over the past two decades with a new profile that complements our paradigm shift in how we define ‘dialysis adequacy’ in paediatrics. The dialysis dose delivered by PD and standard in-centre HD is adequate to reduce mortality. In contrast an increase in dialysis hours per week at home delivers gentler dialysis prescriptions that result in more holistic, multifaceted treatment outcomes that are trending towards ‘optimising’ health and well-being, with the added benefit of a reduced delivery cost. Despite the positive narrative around HHD programs, uptake is still slow worldwide, and the evidence base in children is scarce. Individual departments struggle to secure the investment and commitment required to deliver a safe and effective HHD program which for many patients is a bridging therapy to transplantation. We present practical insights, experiences and outcomes from paediatric experts internationally which demonstrate the benefits for individual children and the possibility of paediatric HHD at service or population level. The description is inspiring and creates a vision for delivering more optimal dialysis with a pragmatic consideration of the ‘value added’ for a local service.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: long-term clinical metabolic results. Kidney Int Suppl. 1988;24:S137–40.

    CAS  PubMed  Google Scholar 

  2. US Renal Data System: USRDS (2003) Annual Report. Bethesda, The National Institute of Diabetes and Digestive and Kidney Diseases. 2003.

    Google Scholar 

  3. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Haemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance Haemodialysis. N Engl J Med. 2002;347:2010–9.

    Article  Google Scholar 

  4. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in Haemodialysis patients. J Am Soc Nephrol. 2002;13:1061–6.

    PubMed  Google Scholar 

  5. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK. Longer treatment time and slower ultrafiltration in Haemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222–8.

    Article  CAS  Google Scholar 

  6. Marshall MR, Byrne BG, Kerr PG, McDonald SP. Associations of Haemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int. 2006;69:1229–36.

    Article  CAS  Google Scholar 

  7. Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant. 2007;22(12):3547–52.

    Article  Google Scholar 

  8. Chou JA, Streja E, Nguyen DV, Rhee CM, Obi Y, Inrig JK, Amin A, Kovesdy CP, Sim JJ, Kalantar-Zadeh K. Intradialytic hypotension, blood pressure changes and mortality risk in incident Haemodialysis patients. Nephrol Dial Transplant. 2018;33(1):149–59.

    Article  CAS  Google Scholar 

  9. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Haemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4(12):1925–31.

    Article  Google Scholar 

  10. Hothi DK, Rees L, Marek J, Burton J, McIntyre CW. Pediatric myocardial stunning underscores the cardiac toxicity of conventional Haemodialysis treatments. Clin J Am Soc Nephrol. 2009;4(4):790–7.

    Article  CAS  Google Scholar 

  11. Hothi D, Sinnott K, Stronach L. Home Haemodialysis in children. Hemodial Int. 2016;20(3):349–57.

    Article  Google Scholar 

  12. Geary DF, Piva E, Tyrrell J, Gajaria MJ, Picone G, Keating LE, Harvey EA. Home nocturnal Haemodialysis in children. J Pediatr. 2005;147:383–7.

    Article  Google Scholar 

  13. Mackenzie P, Mactier RA. Home haemodialysis in the 1990’s. Nephrol Dial Transplant. 1998;13:1944–8.

    Article  CAS  Google Scholar 

  14. Hogan J, Couchoud C, Bonthuis M, Groothoff JW, Jager KJ, Schaefer F, Van Stralen KJ, ESPN/ERA-EDTA Registry. Gender disparities in access to pediatric renal transplantation in Europe: data from the ESPN/ERA-EDTA Registry. Am J Transplant. 2016;16(7):2097–105.

    Article  CAS  Google Scholar 

  15. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N, for the Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin (PreCLOT) Study Group. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med. 2011;364:303–12.

    Article  CAS  Google Scholar 

  16. Sagedal S, Hartmann A, Sundstrom S, et al. A single dose of dalteparin effectively prevents clotting during haemodialysis. Nephrol Dial Transplant. 1999;14:1943–7.

    Article  CAS  Google Scholar 

  17. Lutkin M, Stronach L, Yadav P, Hothi DK. Dalteparin anticoagulation in paediatric home haemodialysis. Pediatr Nephrol. 2018;33(12):2337–41.

    Article  Google Scholar 

  18. Reichwald-Klugger E, Tieben-Heibert A, Korn R, Stein L, Weck K, Maiwald G, Mehls O, Diekmann L, Müller-Wiefel DE, Jochmus I. Psychosocial adaptation of children and their parents to hospital and home Haemodialysis. Int J Pediatr Nephrol. 1984;5(1):45–52.

    CAS  PubMed  Google Scholar 

  19. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily Haemodialysis. Am J Kidney Dis. 2003;42:1020–35.

    Article  Google Scholar 

  20. Puñal J, Lema LV, Sanhez-Guisande D, Ruano-Ravina A. Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review. Nephrol Dial Transplant. 2008;23:2634–46.

    Article  Google Scholar 

  21. Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, Chan CT. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant. 2009;24:2915–9.

    Article  Google Scholar 

  22. Agar J. Nocturnal haemodialysis in Australasia. Nephrology. 2005;10:222–30.

    Article  Google Scholar 

  23. Bergman A, Fenton SS, Richardson RM, Chan CT. Reduction in cardiovascular related hospitalization with nocturnal home Haemodialysis. Clin Nephrol. 2008;69(1):33–9.

    Article  CAS  Google Scholar 

  24. Yuen D, Pierratos A, Richardson RMA, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant. 2006;21(5):1407–12.

    Article  Google Scholar 

  25. Chan CT, Liu PP, Arab S, Jamal N, Messner HA. Nocturnal Haemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells. J Am Soc Nephrol. 2009;20(3):665–71.

    Article  Google Scholar 

  26. Fong E, Bargman JM, Chan CT. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home Haemodialysis versus peritoneal dialysis. Clin J Am Soc Nephrol. 2007;2:1195–200.

    Article  Google Scholar 

  27. Simonsen O. Slow nocturnal dialysis as a rescue treatment for children and young patients with end-stage renal failure. J Am Soc Nephrol. 2000;11:327A.

    Google Scholar 

  28. Geary DF, Piva E, Gajaria M, Tyrrel J, Picone G, Harvey E. Development of a nocturnal home haemodialysis (NHHD) program for children. Semin Dial. 2004;17(2):115–7.

    Google Scholar 

  29. Hothi DK, Piva E, Keating L, Secker D, Harvey E, Geary D. Calcium and phosphate balance in children on home nocturnal hHaemodialysis. Pediatr Nephrol. 2006;21:835–41.

    Article  Google Scholar 

  30. Melhem NZ, Yadav P, Stronach L, Hothi DK. Intensified home haemodialysis for managing severe cardiac failure. Pediatr Nephrol. 2015;30(3):533–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Great Ormond Street Hospital for Children Foundation Trust, London, UK

    Daljit K. Hothi

  2. Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine, Heidelberg, Germany

    Claus Peter Schmitt

Authors
  1. Daljit K. Hothi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claus Peter Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daljit K. Hothi .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Missouri-Kansas City, School of Medicine, Division of Pediatric Nephrology, Children’s Mercy Kansas City, Kansas City, MO, USA

    Bradley A. Warady

  2. Stanford University School of Medicine, Division of Pediatric Nephrology, Department of Pediatrics, Palo Alto, CA, USA

    Steven R. Alexander

  3. Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hothi, D.K., Schmitt, C.P. (2021). Home Haemodialysis in Children. In: Warady, B.A., Alexander, S.R., Schaefer, F. (eds) Pediatric Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-030-66861-7_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-66861-7_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-66860-0

  • Online ISBN: 978-3-030-66861-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation